[en] There is an interest in polylactide microspheres that biodegrade within a few days, particularly for chemoembolization applications. For this purpose, two poly(DL-lactide) samples of a very different molecular weight have been combined. The basic concept relies upon the capability of the high molecular weight component (Mn: 65 000) to provide the microspheres with a high mechanical strength, whereas the low molecular weight component (Mn: 3500) should decrease the particle lifetime dramatically. It has been shown that changing the weight ratio of these two components is an efficient way to control the kinetics of the in vitro degradation of poly(DL-lactide) microspheres on the expected time scale. The microspheres have been prepared by the oil-in-water emulsion/evaporation process, and their final polymer content has been compared to the initial composition of the oil phase. They have also been analyzed by differential scanning calorimetry to know whether the two polymers form a monophase blend or not. Kinetics of the in vitro biodegradation has been estimated from the decrease in molecular weight of the constitutive poly(DL-lactide)s, the time-dependency of the microsphere weight and the observation of changes in the morphology by scanning electron microscopy. Progress in the hydrolysis of the ester groups has also been reckoned from the increasing acidity of the incubation medium and associated with the polymer.
Research center :
Center for Education and Research on Macromolecules (CERM)
Disciplines :
Chemistry Materials science & engineering
Author, co-author :
Grandfils, Christian ; Université de Liège - ULiège > Department of Chemistry > Center for Education and Research on Macromolecules (CERM)
Flandroy, P.; Université de Liège - ULiège, University Hospital Center (CHU) > Department of Medical Imaging
Jérôme, Robert ; Université de Liège - ULiège > Department of Chemistry > Center for Education and Research on Macromolecules (CERM)
Language :
English
Title :
Control of the biodegradation rate of poly(DL-lactide) microparticles intended as chemoembolisation materials
FRSM - Fonds de la Recherche Scientifique Médicale [BE] BELSPO - SPP Politique scientifique - Service Public Fédéral de Programmation Politique scientifique
T. Kato, R. Nemoto, H. Mori, M. Takahashi and M. Harada, Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organ, Cancer 48 (1981) 674-680.
J.P. Benoit, P. Couvreur, J.P. Devissaguet, H. Fessi, F. Puisieux and L. Roblot-Treupel, Les formes vectorialisées ou à distribution modulée, nouveau systèmes d'administration des médicaments, J. Pharm. Belg. 41 (1986) 319-329.
P. Flandroy, C. Grandfils and R. Jérôme, Clinical applications of microspheres in embolizalion and chemoembolization; a comprehensive review and perspectives, in: A. Rolland (Ed.), Pharmaceutical Particulate Carriers in Medical Applications, Vol. 61, Marcel Dekker, New York., 1993, pp. 321-366.
P. Madoule, P. Trampont and A. Roche, Chemoembolization: principles and perspectives, J. Microencapsul. 1 (1984) 21-25.
T. Ichihara, K. Sakamoto, K. Mori and M. Akagi, Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride, Cancer Res. 49 (1989) 4357-4362.
K. Juni, J. Ogata, M. Nakano, T. Ichihara, K. Mori and M. Akagi, Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin, Chem. Pharm. Bull. 33 (1985) 313-318.
G. Spenlehauer, M. Veillard and J.-P. Benoit, Formation and characterization of Cisplatin loaded poly(d,1)lactide microspheres for chemoembolization, J. Pharm. Sci. 75 (8) (1986) 750-755.
G. Spenlehauer, M. Vert, J.P. Benoit, F. Chabot and M. Veillard, Biodegradation cisplatin microspheres prepared by the solvent evaporation method: morphology and release charcteristics, J. Control. Release 7 (1988) 217-229.
G.E. Visscher, R.L. Robison, H.V. Maulding, J.W. Fong, J.E. Pearson and G.J. Argentieri, Biodegradation of and tissue reaction to poly( DL-lactide) microcapsules, J. Biomed. Mater. Res. 20 (1986) 667-676.
H.V. Maulding, T.R. Tice, D.R. Cowsar, J.W. Fong, J.E. Pearson and J.P. Nazareno, Biodegradable microcapsules: acceleration of polymeric excipient. Hydrolytic rate by incorporation of a basic medicament, J. Control. Release 3 (1986) 103-117.
Y. Cha and C.G. Pitt, The acceleration of degradation-controlled drug delivery from polyester microspheres, J. Control. Release 8 (1989) 259-265.
R. Bodmeier, K.H. Oh and H. Chen, The effect of the addition of low molecular weight poly ( DL-lactide ) on drug release from biodegradable poly (DL-lactide) drug delivery systems, Int. J. Pharm. 51 (1989) 1-8.
C. Grandfils, P. Flandroy, N. Nihant, S. Barbette, R. Jérôme and P. Teyssié. Preparation of poly(DL)lactide microspheres and their clinical applications as a convenient embolic material, J. Biomed. Mater. Res. 26 (1992) 467-479.
J.A.P.P. Van Dijk and J.A.M. Smit, Characterization of poly(DL-lactic acid) by gel permeation chromatography, J. Pharm. Sci. 21 (1983) 197-208.
T. St. Pierre and E. Chiellini, Biodegradability of synthetic polymers used for medical and pharmaceutical applications: part 1 - principles of hydrolysis mechanisms, J. Bioact. Compat. Polym. 1 (1986) 467-497.
M. Vert, S. Li and H. Garreau, More about the degradation of LA/GA-derived matrices in aqueous media. J. Control. Release 16 (1991) 15-26.
S. Li and M. Vert, Crystalline oligomeric stereocomplex as an intermediate compound in racemic poly(DL-lactic acid) degradation, Polym. Int. 33 (1994) 37-41.
B. Wiehert and P. Rohdewald, A new method for the preparation of drug containing polylactic acid microparticles without using organic solvents, J. Control. Release 14 (1990) 269-283.
A. Celli and M. Scandola, Thermal properties and physical ageing of poly(L-lactic acid), Polymer 33 (1992) 2699-2703.
S. Harley, D.W. Thompson and B. Vincent, The adsorption of small particles onto larger particles of opposite charge. Direct electron microscope studies, Colloids Surfaces 62 (1992) 163-176.
S.S. Shah, Y. Cha and C.G. Pitt, Poly(glycolic acid-co-DL-lactic acid) - Diffusion or degradation controlled drug delivery, J. Control. Release 18 (1992) 261-270.
G. Spenlehauer, M. Vert, J.P. Benoît and A. Boddaert, In vitro and in vivo degradation of poly(DL)lactide/glycolide type microspheres made by solvent evaporation method, Biomaterials 10 (1989) 557-563.
K. Makino, H. Ohshima and T. Kondo, Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effect of pH, ionic strength and buffer concentration, J. Microencapsul. 3 (1986) 203-212.
R.A. Kenley, M.O. Lee, T.R. Mahoney and L.M. Sanders, Poly (lactide-co-glycolide) decomposition kinetics in vivo and in vitro, Macromolecules 20 (1987) 2398-2403.